Clinical Trials on Supplements in Austria
Total 2 results
-
Medical University of ViennaCompletedPerioperative | Brain Natriuretic Peptide | Supplemental Oxygen | Cardiac Risk PatientsAustria
-
PharmanexClinical Research AustraliaRecruiting
Sponsors and Collaborators
- Fredensborg Kommune
- National Association of Pediatric Nurse Practitioners
- Universiti Sains Malaysia
- Heinrich Elinzano, MD
- Netherlands Thrombosis Foundation
- Vensica Therapeutics Ltd.
- Steven R. Sanislo
- The Susanne Marcus Collins Foundation, Inc
- St. Francis Hospital, New York
- 3D Medicines (Beijing) Co., Ltd.
- Geno LLC
- Centre for Preventative Doping Research at the German Sport University Cologne, Germany
- Satoshi Shizuta
- Santa Casa de Juiz de Fora - MG
- ADHAD
- Centre Hospitalier Univeritaire Sainte Justine
- IRegained Inc.
- Singapore Millennium Foundation
- BRIM Biotechnology Inc.
- Nicolai Goettel
- View Full List
Medical Conditions
- Craniosynostosis Repair
- Absence of an HLA Identical Donor
- Epithelial Ovarian Carcinoma Stage III
- Hemorrhoids Fourth Degree
- Corneal Opacities
- Infection Due to Resistant Organism
- Smoking Cessation Counseling Practice
- Recurrent Malignant Mesothelioma
- Prone Position
- Incidence of Mesh Infection In Hernioplasty
- Dementia Senile
- Healthcare Professionals
- Recurrent/Refractory Lymphoma
- Tay-Sachs Disease, AB Variant
- Hypoestrogenemia
- Non-Arteritic Anterior Ischemic Optic Neuropathy
- Facial Mask From Snake Fruit
- Calcaneonavicular Coalition
- Malignant Brain Neoplasm
- SLC6A1
- View Full List
Drug Interventions
- Duloxetine hydrochloride enteric-coated capsules
- Sofosbuvir/velpatasvir
- Capecitabine (Xeloda)
- Sorafenib
- Daratumumab
- AZD7268
- Palonosetron, aprepitant, dexamethasone
- Articaine and Epinephrine Only Product
- Azacitidine
- Follicle Stimulating Hormone (FSH)
- Cyclophosphamide
- Cemiplimab Injection [Libtayo]
- Valsartan
- S-ketamine (low-dose)
- Nivolumab-daratumumab with low-dose cyclophosphamide
- Ropivacaine
- Lyso-thermosensitive Liposomal Doxorubicin
- Benralizumab 30 mg/ml
- EGFR/EGFRvIII Inhibitor WSD0922-FU
- Rituximab
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Russia
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Uzbekistan
- CRO list by country